Please assess the completion status of the following clinical trial:

Trial Title: Inhibition of Food Intake in Response to Oral GLP-1 and Peptide YY3-36

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1/PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* healthy male subjects~* no evidence of disease~* no history of gastrointestinal or endocrine disorders~Exclusion Criteria:~* alcohol and drug abuse~* history of gastrointestinal or endocrine disorders~* female subjects

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- ORAL GLP-1, TABLET (Type: ACTIVE_COMPARATOR): None
- Oral PYY3-36 (Type: ACTIVE_COMPARATOR): None
- Oral GLP-1 plus oral PYY3-36 (Type: ACTIVE_COMPARATOR): None
- 4 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).